Mohammad Thawabi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Thawabi has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Marc Cohen
Division of Cardiology, Department of Medicine, Newark Beth Israel Medical Center, 201 Lyons Ave, Newark, NJ 07112, United States
18 shared publicationsFayez Shamoon
Department of Cardiology, New York Medical College, St. Joseph Medical Center, 703 Main Street, Paterson, NJ 07503, USA
15 shared publications- Amer Hawatmeh
Department of Cardiology, Saint Michael's Medical Center, New York Medical College, New Jersey, USA
13 shared publications Amer Hawatmeh
Department of Cardiology, Newark Beth Israel Medical Center, Newark, New Jersey
11 shared publicationsSarah Studyvin
Newark Beth Israel Medical Center, Newark, New Jersey, United States
10 shared publicationsAshraf Jmeian
Department of Internal Medicine, St. Michael's Medical Center, An Affiliate of New York Medical College, New York, USA
5 shared publications
Latest Publications
- 1 February 2020
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (2) , 176-179
Implications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes
- 1 February 2020
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 21 (2) , 176-179
Implications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes
- 27 May 2019
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 94 (2) , 243-248
Percutaneous transaxillary approach for peripheral endovascular interventions
Objectives: To assess the safety and feasibility of percutaneous transaxillary (TAx) access for peripheral endovascular interventions.Background: The common femoral artery (CFA) is the most commonly used access site for peripheral endovascular interventions. However, its use might be precluded in multiple circumstances. The axillary artery is comparable in size to the CFA and is less affected by atherosclerosis. Data regarding its percutaneous use in peripheral endovascular interventions are scarce.Methods: Consecutive patients who underwent percutaneous TAx peripheral endovascular interventions were identified. Demographic and periprocedural data were extracted. Axillary artery access was obtained percutaneously with the arm abducted. A destination sheath was advanced to the relevant vessel. Endovascular interventions were performed using standard devices and techniques. Vascular closure devices were utilized to achieve hemostasis. Primary endpoints included procedural technical success, access‐related complications, and major adverse events (MAEs). Secondary endpoints included cannulation time, total procedure time, fluoroscopy time, and length of stay (LOS).Results: Percutaneous TAx access was successfully utilized to perform 41 procedures in 29 patients, lacking a suitable conventional access. Three quarters of target vessels were infrainguinal. The lesions of 61% were classified as TransAtlantic Inter‐Society Consensus (TASC) C or D. Access‐related complications occurred in two procedures (5%). No MAEs occurred. Median cannulation time was 12 min, procedure time 135 min, fluoroscopy time 20 min, and LOS 1 day.Conclusions: When no suitable access exists for lower extremity catheter‐based interventions, percutaneous TAx approach is a feasible and safe alternative. As such facility with this approach is a valuable asset for interventionalists.
- 27 May 2019
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 94 (2) , 243-248
Percutaneous transaxillary approach for peripheral endovascular interventions
Objectives: To assess the safety and feasibility of percutaneous transaxillary (TAx) access for peripheral endovascular interventions.Background: The common femoral artery (CFA) is the most commonly used access site for peripheral endovascular interventions. However, its use might be precluded in multiple circumstances. The axillary artery is comparable in size to the CFA and is less affected by atherosclerosis. Data regarding its percutaneous use in peripheral endovascular interventions are scarce.Methods: Consecutive patients who underwent percutaneous TAx peripheral endovascular interventions were identified. Demographic and periprocedural data were extracted. Axillary artery access was obtained percutaneously with the arm abducted. A destination sheath was advanced to the relevant vessel. Endovascular interventions were performed using standard devices and techniques. Vascular closure devices were utilized to achieve hemostasis. Primary endpoints included procedural technical success, access‐related complications, and major adverse events (MAEs). Secondary endpoints included cannulation time, total procedure time, fluoroscopy time, and length of stay (LOS).Results: Percutaneous TAx access was successfully utilized to perform 41 procedures in 29 patients, lacking a suitable conventional access. Three quarters of target vessels were infrainguinal. The lesions of 61% were classified as TransAtlantic Inter‐Society Consensus (TASC) C or D. Access‐related complications occurred in two procedures (5%). No MAEs occurred. Median cannulation time was 12 min, procedure time 135 min, fluoroscopy time 20 min, and LOS 1 day.Conclusions: When no suitable access exists for lower extremity catheter‐based interventions, percutaneous TAx approach is a feasible and safe alternative. As such facility with this approach is a valuable asset for interventionalists.
- 1 July 2018
- Published by Elsevier in Heart & Lung
- Vol. 47 (4) , 429-431
Amiodarone induced myxedema coma: Two case reports and literature review
- 1 July 2018
- Published by Elsevier in Heart & Lung
- Vol. 47 (4) , 429-431
Amiodarone induced myxedema coma: Two case reports and literature review
- 1 April 2018
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 8 (2) , 164-172
Value of neutrophil to lymphocyte ratio as a predictor of mortality in patients undergoing aortic valve replacement
Background: Neutrophil to lymphocyte ratio (NLR) has been studied as a measure of inflammation and as a prognosticating factor in various medical conditions including neoplastic, inflammatory and cardiovascular. The prognostic role of NLR in predicting mortality in patients with aortic stenosis undergoing surgical aortic valve replacement (AVR) has not been studied. The aim of our study is to explore the utility of NLR as a predictor of both, short and long-term mortality, in patients undergoing surgical AVR. Methods: Consecutive patients with aortic stenosis admitted for AVR to our institution were evaluated for study inclusion. Of the 335 patients admitted from January 2007 to September 2011, 234 met study inclusion criteria. Patients were divided into two groups depending on their initial preoperative NLR level with a cutoff value of 3. Three-year vital status was accessed with electronic medical records and Social Security Death Index. Survival analysis, stratified by NLR, was used to evaluate the predictive value of preoperative NLR levels. Results: Patients with NLR ≥3, when compared to those with NLR vs. 0, P=0.0006), 6-month (19.54% vs. 0.95%, Pvs. 3.78%, PConclusions: NLR is an independent predictor of short-term and long-term mortality in patients with aortic stenosis undergoing AVR surgery, especially those with NLR ≥3. We strongly suggest the use of NLR as a tool to risk stratify patients with aortic stenosis undergoing AVR surgery.
- 1 April 2018
- Published by AME Publishing Company in Cardiovascular Diagnosis and Therapy
- Vol. 8 (2) , 164-172
Value of neutrophil to lymphocyte ratio as a predictor of mortality in patients undergoing aortic valve replacement
Background: Neutrophil to lymphocyte ratio (NLR) has been studied as a measure of inflammation and as a prognosticating factor in various medical conditions including neoplastic, inflammatory and cardiovascular. The prognostic role of NLR in predicting mortality in patients with aortic stenosis undergoing surgical aortic valve replacement (AVR) has not been studied. The aim of our study is to explore the utility of NLR as a predictor of both, short and long-term mortality, in patients undergoing surgical AVR. Methods: Consecutive patients with aortic stenosis admitted for AVR to our institution were evaluated for study inclusion. Of the 335 patients admitted from January 2007 to September 2011, 234 met study inclusion criteria. Patients were divided into two groups depending on their initial preoperative NLR level with a cutoff value of 3. Three-year vital status was accessed with electronic medical records and Social Security Death Index. Survival analysis, stratified by NLR, was used to evaluate the predictive value of preoperative NLR levels. Results: Patients with NLR ≥3, when compared to those with NLR vs. 0, P=0.0006), 6-month (19.54% vs. 0.95%, Pvs. 3.78%, PConclusions: NLR is an independent predictor of short-term and long-term mortality in patients with aortic stenosis undergoing AVR surgery, especially those with NLR ≥3. We strongly suggest the use of NLR as a tool to risk stratify patients with aortic stenosis undergoing AVR surgery.